Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.
about
A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review.The renin-angiotensin system and prolylcarboxypeptidase.
P2860
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@en
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@nl
type
label
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@en
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@nl
prefLabel
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@en
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@nl
P2093
P2860
P50
P1476
Prolylcarboxypeptidase deficie ...... ng and cardiac angiotensin II.
@en
P2093
Alvin H Schmaier
Brian D Hoit
Christopher A Flask
Daniel Batlle
Gregory N Adams
Ines Schadock
Jan Wysocki
Minghao Ye
Philipp K Haber
Yashpal Kanwar
P2860
P2888
P304
P356
10.1007/S00109-017-1513-9
P577
2017-02-03T00:00:00Z